title: Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietin.
authors.forename: K
authors.initials: K
authors.lastname: Jandeleit
authors.forename: B
authors.initials: B
authors.lastname: Heintz
authors.forename: E
authors.initials: E
authors.lastname: Gross-Heitfeld
authors.forename: J
authors.initials: J
authors.lastname: Kindler
authors.forename: H G
authors.initials: HG
authors.lastname: Sieberth
authors.forename: R
authors.initials: R
authors.lastname: Kirsten
authors.forename: K
authors.initials: K
authors.lastname: Nelson
mesh_terms: D000804:Angiotensin II / Q000008:administration & dosage; D001341:Autonomic Nervous System / Q000187:drug effects* / Q000503:physiopathology; D004351:Drug Resistance; D004921:Erythropoietin / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D009638:Norepinephrine / Q000097:blood; D006435:Renal Dialysis
chemical_list: D004921:Erythropoietin; D000804:Angiotensin II; D009638:Norepinephrine